- May 04, 2017
Disrupting an omega-3 fatty acid transporter could open blood-brain barrier for drug delivery
- November 16, 2016
Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment
- October 14, 2016
First annual Harvard FUSION symposium assembles leaders at the convergence of science and business
- April 27, 2016
Five research projects with commercial potential receive sustaining funding through Harvard’s Physical Sciences & Engineering Accelerator.
- August 19, 2015
Twelve advanced research projects aimed at developing new therapies and diagnostics receive support in 2015-16 from Harvard’s Blavatnik Biomedical Accelerator.
Page 1 of 3